Saturday, November 22, 2025
HomeIndustries

Industries

Aeglea BioTherapeutics Presents Additional Data from PEACE Phase 3 Study of Pegzilarginase for the Treatment of Arginase 1 Deficiency at SIMD

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics to benefit people with rare metabolic diseases, shared additional...

PureTech Announces Publication of Research from Collaborators Demonstrating PureTech’s Glyph Platform

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, announced the publication of preclinical...

Aviva Systems Biology Announces the Launch of High Throughput Antibody Characterization Services

Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, announced the launch of its new service...

Embark Introduces New Auto Insurance Product Tailored to Underserved Florida Drivers

Embark, the next generation insurance MGA, has expanded availability of its auto insurance program to Florida through its partnership with Incline P&C Group, providing...

Senmiao Technology Announces Ride-Hailing Platform Operating Metrics for March 2022

Senmiao Technology Limited, a financing and servicing company focused on the online ride-hailing industry in China, as well as an operator of its own...
0FansLike
0FollowersFollow
spot_img

Hot Topics